Sphera Funds Management »

Chemomab Therapeutics shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Chemomab Therapeutics (CMMB) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Chemomab Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 291.9M2M2.1M2.2M1.214574M1.2145745M1.214575M1.2145755M1.214576M
Value ($)Share countHistorical CMMB position of Sphera Funds Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Chemomab Therapeutics held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chemomab Therapeutics by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.2M 1.2M 1.81
2024-09-30 $1.9M 1.2M 1.57

More positions owned by Sphera Funds Management

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Bridgebio Pharma (BBIO)
Sanofi Sponsored Adr (SNY)
Syndax Pharmaceuticals (SNDX)
Astrazeneca Sponsored Adr (AZN)
Amazon (AMZN)
Praxis Precision Medicines I Com New (PRAX)
NOVA MEASURING Instruments L (NVMI)
Meta Platforms Cl A (META)
Sarepta Therapeutics (SRPT)
Celldex Therapeutics Com New (CLDX)
Eledon Pharmaceuticals (ELDN)
Eli Lilly & Co. (LLY)
Johnson & Johnson (JNJ)
Ultragenyx Pharmaceutical (RARE)

View all positions for Sphera Funds Management

Top funds holding Chemomab Therapeutics

OrbiMed Advisors
Sphera Funds Management
Yelin Lapidot Holdings Management
Ikarian Capital
Morgan Stanley
Kestra Private Wealth Services
Boothbay Fund Management
XTX Topco
Rhumbline Advisers
Virtu Financial
Wetzel Investment Advisors
Bnp Paribas Arbitrage, Snc
GAMMA Investing
Moser Wealth Advisors
UBS Group

View all funds holding Chemomab Therapeutics